Curaleaf Holdings (CURLF) Free Cash Flow (QoQ) (2019 - 2024)
Curaleaf Holdings (CURLF) Free Cash Flow (QoQ) (2019 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 91.93 Bn | 90.07 Bn | - |
| 2 | Teva Pharmaceutical Industries | 36.31 Bn | 32.57 Bn | 1.97 Bn |
| 3 | Zoetis | 33.01 Bn | 31.07 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.65 Bn | 23.59 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.96 Bn | 20.81 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.50 Bn | 18.69 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 18.16 Bn | 16.85 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.84 Bn | 12.41 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 6.71 Bn | 6.71 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -146.52% |
| Sep 30, 2024 | 100.16% |
| Jun 30, 2024 | -199.83% |
| Mar 31, 2024 | 115,494.35% |
| Dec 31, 2023 | -161.01% |
| Sep 30, 2023 | 100.79% |
| Jun 30, 2023 | -199.81% |
| Mar 31, 2023 | 3,929.16% |
| Dec 31, 2022 | -568.85% |
| Sep 30, 2022 | 219.43% |
| Jun 30, 2022 | -142.13% |
| Mar 31, 2022 | 267.86% |
| Dec 31, 2021 | -75.17% |
| Sep 30, 2021 | 406.47% |
| Jun 30, 2021 | -222.74% |
| Mar 31, 2021 | 114.35% |
| Dec 31, 2020 | -1,050.41% |
| Sep 30, 2020 | -64.31% |
| Jun 30, 2020 | 148.30% |
| Mar 31, 2020 | 112.60% |